Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,733.50
Bid: 1,732.50
Ask: 1,733.00
Change: 5.00 (0.29%)
Spread: 0.50 (0.029%)
Open: 1,733.00
High: 1,739.50
Low: 1,724.50
Prev. Close: 1,728.50
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UPDATE 1-Top scientists warn WHO not to stub out e-cigarettes

Thu, 29th May 2014 11:28

* Concern that UN agency sees e-cigarettes as "threat"

* Classification as tobacco products would curb use

* Scientists say e-cigarettes "part of solution" to smoking

* Critics say safety uncertain, risk of fuelling addiction (Adds comment from British Lung Foundation, declaration fromscientists on competing interest)

By Ben Hirschler

LONDON, May 29 (Reuters) - A group of 53 leading scientistshas warned the World Health Organisation not to classifye-cigarettes as tobacco products, arguing that doing so wouldjeopardise a major opportunity to slash disease and deathscaused by smoking.

The UN agency, which is currently assessing its position onthe matter, has previously indicated it would favour applyingsimilar restrictions to all nicotine-containing products.

In an open letter to WHO Director General Margaret Chan, thescientists from Europe, North America, Asia and Australia arguedthat low-risk products like e-cigarettes were "part of thesolution" in the fight against smoking, not part of the problem.

"These products could be among the most significant healthinnovations of the 21st century - perhaps saving hundreds ofmillions of lives. The urge to control and suppress them astobacco products should be resisted," the experts wrote.

Leaked documents from a meeting last November suggest theWHO views e-cigarettes as a "threat" and wants them classifiedthe same way as regular tobacco products under the FrameworkConvention on Tobacco Control (FCTC). (http://link.reuters.com/muq69v)

That has set alarm bells ringing among a number of medicalexperts - and in the booming e-cigarette industry. A total of178 countries are parties to the international convention andare obliged to implement its measures, with the United Statesthe one notable non-signatory.

A move to classify e-cigarettes alongside regular cigaretteswould push countries into taking similar tough measures torestrict demand, including raising taxes, banning advertising,introducing health warnings and curbing use in public places.

Uptake of electronic cigarettes, which use battery-poweredcartridges to produce a nicotine-laced inhalable vapour, hasrocketed in the last two years and analysts estimate theindustry had worldwide sales of some $3 billion in 2013.

But the devices are controversial. Because they are so newthere is a lack of long-term scientific evidence to supporttheir safety and some fear they could be "gateway" products tonicotine addiction and tobacco smoking - though the scientistssaid they were "unaware of any credible evidence that supportsthis conjecture".

In response to the scientists' letter, Penny Woods, chiefexecutive of the British Lung Foundation, said: "The overallimpact of e-cigarette use on public health is currently unclear.While they could prove to be an important tool to help peoplestop smoking, the unregulated status of e-cigarettes isproblematic."

BIG TOBACCO BACKS SCIENTISTS

For tobacco companies seeking to offset the decline intraditional smoking, investment in e-cigarettes was an obviouschoice and all the major players now have a presence, promptingBig Tobacco to line up behind scientists on this occasion.

Kingsley Wheaton, director of corporate and regulatoryaffairs at British American Tobacco, said classifyinge-cigarettes as tobacco products would mean smokers find itharder to access a less risky alternative.

In a declaration of interests, none of the scientists saidthey had received funding from tobacco companies. However, somehave carried out research on e-cigarettes or acted asconsultants for drug companies making other smoking cessationproducts, including GlaxoSmithKline, Johnson & Johnson and Pfizer.

The Geneva-based WHO said its position on e-cigarettes wasstill in flux ahead of a key meeting on the FCTC scheduled forOctober 13-18 in Moscow, where proposed regulations will bediscussed.

"At this point the only thing I can say is that we areelaborating these regulations and they will soon be available toyou," Armando Peruga, programme manager for the WHO's TobaccoFree Initiative told reporters this week.

Gerry Stimson, emeritus professor at Imperial College Londonand one of the organisers of the letter to Chan, told Reutersthat the WHO's position was "bizarre" and its stance one-cigarettes was harsher than that of regulators in Europe andthe United States.

"We want to make sufficient noise now before things get tooset in stone," he said. (Additional reporting by Tom Miles in Geneva; Editing by DavidEvans and Pravin Char)

More News
2 May 2024 19:57

GSK knew about Zantac cancer risk, attorneys tell jury in first trial

May 2 (Reuters) - U.S. attorneys for a woman who claims her colon cancer was caused by the now discontinued heartburn drug Zantac on Thursday told a jury in Chicago that pharmaceutical companies GSK and Boehringer Ingelheim knew the product could cause cancer if it was not handled properly but failed to warn the public.

Read more
2 May 2024 09:48

LONDON BROKER RATINGS: Deutsche Bank likes TP ICAP but says sell CMC

(Alliance News) - The following London-listed shares received analyst recommendations Thursday morning and Wednesday:

Read more
1 May 2024 19:39

Bird flu testing shows more dairy products are safe, US FDA says

CHICAGO, May 1 (Reuters) - Preliminary results of tests on additional dairy products show that pasteurization inactivates the bird flu virus, the U.S. Food and Drug Administration said on Wednesday.

Read more
1 May 2024 17:31

UK's FTSE 100 slips ahead of Fed outcome, energy stocks weigh

FTSE 100 down 0.3%, FTSE 250 off 0.2%

*

Read more
1 May 2024 16:56

LONDON MARKET CLOSE: FTSE 100 down ahead of US interest rate decision

(Alliance News) - Stock prices in London closed mostly in the red on Wednesday, as investors eye the latest interest rate decision from the US Federal Reserve this evening.

Read more
1 May 2024 16:42

London close: Stocks fall ahead of US Fed decision

(Sharecast News) - London markets closed lower on Wednesday, as investors digested the latest UK manufacturing data and anticipated an impending policy announcement from the US Federal Reserve.

Read more
1 May 2024 11:55

LONDON MARKET MIDDAY: FTSE 100 treads water as Fed takes centre-stage

(Alliance News) - London's FTSE 100 traded off session highs heading into Wednesday afternoon, as some pre-Federal Reserve decision nerves kicked in.

Read more
1 May 2024 10:54

GSK raises profit outlook on strong vaccine, HIV drug sales

FY profit forecast raised to 8-10%

*

Read more
1 May 2024 08:57

LONDON MARKET OPEN: FTSE 100 shakes off New York slump before Fed

(Alliance News) - Stock prices in London opened mixed on Wednesday, with the FTSE 100 brushing off some pre-Federal Reserve decision trepidation to record an early rise, while the dollar climbed on the expectation that Jerome Powell will sound hawkish in his press conference later.

Read more
1 May 2024 08:50

TOP NEWS: GSK expects momentum to continue after strong first quarter

(Alliance News) - GSK PLC on Wednesday raised its annual earnings forecast, and said it expects sales growth at the top-end of guidance, after a "strong" start to the year.

Read more
1 May 2024 07:46

LONDON BRIEFING: GSK ups outlook; Next first-quarter beats forecast

(Alliance News) - Equities in London are called to open flat on Wednesday, ahead of the latest Federal Reserve interest rate decision, while a host of financial markets in mainland Europe and beyond are closed for public holidays.

Read more
1 May 2024 07:36

GSK lifts annual guidance on strong virus treatment sales

(Sharecast News) - UK pharmaceutical giant GSK lifted annual profits guidance on Wednesday, as it pinned its hopes on demand for its respiratory virus and shingles treatments.

Read more
30 Apr 2024 23:46

First trial over Zantac cancer claims set to begin in Chicago

April 30 (Reuters) - The first trial over claims that blockbuster heartburn drug Zantac, once sold by GSK and other companies, causes cancer is set to begin this week in Chicago.

Read more
30 Apr 2024 22:39

First trial over Zantac cancer claims set to begin in Chicago

April 30 (Reuters) - The first trial over claims that blockbuster heartburn drug Zantac, once sold by GSK and other companies, causes cancer is set to begin this week in Chicago.

Read more
30 Apr 2024 13:51

Sensodyne maker Haleon to shut UK factory with loss of 435 jobs

(Alliance News) - More than 400 jobs are to be axed at Sensodyne toothpaste and Advil painkillers firm Haleon PLC as the group revealed plans to shut its only manufacturing site in the UK.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.